G(ZZKK)3Z-NH2

General Information


DRACP ID  DRACP02731

Peptide Name   G(ZZKK)3Z-NH2

Sequence  GXXKKXXKKXXKKX

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 60% Killing=50 µM MTT assay 24 h 1
HL-60 Adult acute myeloid leukemia; Acute myeloid leukemia Leukemia >80% Killing=50 µM MTT assay 24 h 1

Hemolytic Activity  Human erythrocytes: HC50=30 µM

Normal (non-cancerous) Cytotoxicity  Human keratinocytes HaCat: 30% Killing=40 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X=Norleucine

Chiral  L



Physicochemical Information


Formula  C38H63N13O

Absent amino acids  ACDEFHILMNPQRSTVWY

Common amino acids  X

Mass  172005

Pl  11.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  0

Net charge  6

Boman Index  -3236

Hydrophobicity  -170

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Amino acid side chains affect the bioactivity of designed short peptide amphiphiles

Doi 10.1039/C6TB00155F

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPS_13932

DRACP is developed by Dr.Zheng's team.